SCHEMBL8620115

SCHEMBL8620115

O=C(CCc1ccc(Cl)cc1Cl)NC1N=C(C2CC2)c2ccccc2N(CC(F)(F)F)C1=O

nearest known ligand 0.68

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.68
OXTR P30559 3/20 0.44
CALCRL Q16602 11/20 0.43
P2RX7 Q99572 2/20 0.43
RAMP1 O60894 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8612435 0.93 KCNH2 (0.76) KCNH2OXTRCALCRLP2RX7RAMP1
SCHEMBL8837133 0.83 KCNH2 (0.75) KCNH2OXTRCALCRLRAMP1
SCHEMBL8619392 0.82 KCNH2 (0.61) KCNH2OXTRCALCRL
SCHEMBL7207946 0.81 KCNH2 (1.00) KCNH2CALCRLRAMP1
SCHEMBL8745078 0.79 KCNH2 (0.89) KCNH2CALCRLRAMP1
SCHEMBL8620108 0.79 KCNH2 (0.77) KCNH2CALCRLRAMP1
SCHEMBL8617494 0.78 KCNH2 (0.60) KCNH2OXTRCALCRLRAMP1
SCHEMBL8615196 0.77 KCNH2 (0.57) KCNH2OXTRCALCRLRAMP1
SCHEMBL8837174 0.77 KCNH2 (0.53) KCNH2CALCRL
SCHEMBL4702944 0.74 KCNH2 (0.63) KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5631251-A 5-cyclopropyl-1,4 benzodiazepine-2-ones MERCK & CO., INC. (US) 1997-05-20 US claimed
EP-0831833-A4 NOVEL 5-CYCLOPROPYL-1,4 BENZODIAZEPINE-2-ONES MERCK & CO INC (US) 1998-10-07 EP disclosed
EP-0831833-A1 NOVEL 5-CYCLOPROPYL-1,4 BENZODIAZEPINE-2-ONES Merck & Co., Inc. (US) 1998-04-01 EP disclosed
US-5631251-A 5-cyclopropyl-1,4 benzodiazepine-2-ones MERCK & CO., INC. (US) 1997-05-20 US disclosed
WO-1996040146-A1 NOVEL 5-CYCLOPROPYL-1,4 BENZODIAZEPINE-2-ONES MERCK & CO., INC. (US) 1996-12-19 WO disclosed